Olvidé mi contraseña
Asóciese a SIIC en Internet para utilizar sin límites tanto siicsalud como la totalidad de los servicios bibliográficos de la institución.
SIIC selecciona textos completos de calidad y de reciente publicación en fuentes prestigiosas del mundo
indizadas por SIIC Data Bases, capturadas en las mismas colecciones o en diversas bases especializadas.
La creciente cantidad de artículos con Acceso Abierto (Open
Access) amplía la oferta de lectura pero a su vez también, entre
tanta abundancia, complica al lector en su encuentro con los estudios
fundamentales. Para facilitarlo, profesionales biomédicos de SIIC
consultan diariamente una profusa cantidad de documentos que nutrirán
Textos completos autorizados (TCA).
Las citas de la sección TCA enlazan de manera legal, autorizada y
gratuita con los textos completos (full text) publicados en
los sitios oficiales de sus respectivas fuentes.
SIIC creó, produjo y opera con exclusividad el software TCA para la
interpretación de los diversos campos documentales que integran la
estructura de un estudio: especialidad, modalidad del estudio,
fuente, fechas de publicación y selección, definición de la fuente,
limitaciones de consulta, resumen en castellano, etc.
Si bien la mayoría de los textos seleccionados corresponden a
artículos originales, revisiones y guías, los lectores también
encontrarán comentarios, entrevistas, notas periodísticas, cartas a
autores u otros textos precursores de debates o aclaratorios.
Sociedad Iberoamericana de Información Científica (SIIC) selects
complete quality-full texts which have been recently published in
renowned sources worldwide and are indexed by SIIC Data
Bases.
The increasing number of Open Access articles widens the reading offer
but, also, such myriad complicates the readers search of fundamental
articles. To facilitate this, SIIC biomedical professionals daily
consult a profuse amount of documents that will feed
Authorized Full Texts (TCA, Spanish acronym).
The citations of the AFT section link legally, authorized and free of
charge with the full texts published in the official web sites of
their corresponding sources.
SIIC created, produced and handles the AFT software that deciphers
the various documentary fields that form part of the structure of a
study: specialty, study style, source, publication and selection
dates, source definition, query limitations, summary in Spanish,
etc.
While most of the selected texts belong to original articles,
reviews, and guidelines, readers will also find commentaries,
interviews, journalistic reports, letters to authors or other texts
that may lead to discussions or clarifications.
Extracto:
This disruption increases the response to doxorubicin and could be tested
clinically.
Cita:Nat Commun 2024 Mar 30; 15 (1) : 2803.
Autor/es:Daneshmandi, Saeed (a) Choi, Jee Eun (b)
institución:(a) Department of Immunology, Roswell Park Comprehensive Cancer Center, Buffalo, New York, NY, USA. (b) Department of Cell Stress Biology, Roswell Park Comprehensive Cancer Center, Buffalo, New York, NY, USA.
Conflicto:P.L.M. has received honoraria from and participated in advisory boards from Bristol Myers Squibb, Bluebird, Celgene, Janssen, Juno, Karyopharm, Magenta Therapeutics, Oncopeptides and Takeda. The other authors have no competing interests to declare.
Prediction of dysphagia aspiration through machine learning-based analysis of patients' postprandial voices.
Prediction of dysphagia aspiration through machine learning-based analysis of patients' postprandial voices.
Fuente:Journal of Neuroengineering and Rehabilitation
Tipo de trabajo:Estudio de cohortes
Extracto:
In this study, we used mel-spectrogram analysis and a MobileNetV3
model for predicting dysphagia aspiration. Our research highlights voice analysis
potential in dysphagia screening, diagnosis, and monitoring, aiming for
non-invasive safer, and more effective interventions. TRIAL REGISTRATION: This
study was approved by the IRB (No. B-2109-707-303) and registered on
clinicaltrials.gov (ID: NCT05149976).
institución:(a) Department of Health Science and Technology, Graduate School of Convergence Science and Technology, Seoul National University, Seoul, South Korea. (b) Department of Rehabilitation Medicine, Seoul National University Bundang Hospital, Seongnam, South Korea.
Conflicto:Dr Ryu, Jung-Min Kim, and Min-Seop Kim reported owing patent No. 10-2023-0095566. This patent is owned by RS Rehab and Bundang Seoul National University Hospital. No other disclosures were reported.
Clinical characterization and outcomes of impulse oscillometry-defined bronchodilator response: an ECOPD cohort-based study.
Clinical characterization and outcomes of impulse oscillometry-defined bronchodilator response: an ECOPD cohort-based study.
Fuente:Respiratory Research
Tipo de trabajo:Estudio clínico
Extracto:
The participants with IOS-BDR had more respiratory
symptoms, radiographic structural changes, and had an increase in decline in lung
function than those without IOS-BDR. TRIAL REGISTRATION: Chinese Clinical Trial
Registry, ChiCTR1900024643. Registered on 19 July, 2019.
Claves:Acute exacerbations, Bronchodilator response, Decline in lung function, Impulse oscillometry, Small airway dysfunction
Cita:Respir Res 2024 Mar 30; 25 (1) : 149.
Autor/es:Lu, Lifei (a) Wu, Fan (b)
institución:(a) State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, National Center for Respiratory Medicine, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China. (b) State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, National Center for Respiratory Medicine, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
Conflicto:Los autores declaran no tener conflictos de interés con la investigación
Coinfection of Influenza A and B and Human OC43 Coronavirus in Normal Human Bronchial Epithelial Cells.
Coinfection of Influenza A and B and Human OC43 Coronavirus in Normal Human Bronchial Epithelial Cells.
Fuente:Influenza and Other Respiratory Viruses
Tipo de trabajo:Guía
Extracto:
As the rate of influenza and seasonal coronavirus coinfection
continue to increase, our findings may help set guidelines for the treatments of
the individuals coinfected with both viruses.
Cita:Influenza Other Respir Viruses 2024 Apr; 18 (4) : e13279.
Autor/es:Kim, JungHyun (a) Hickerson, Brady T (b)
institución:(a) Division of Biotechnology Review and Research II, Food and Drug Administration, Silver Spring, Maryland, USA. (b) Division of Biotechnology Review and Research II, Food and Drug Administration, Silver Spring, Maryland, USA.
Conflicto:Los autores declaran no tener conflictos de interés con la investigación
The epidemic forest reveals the spatial pattern of the spread of acute respiratory infections in Jakarta, Indonesia.
The epidemic forest reveals the spatial pattern of the spread of acute respiratory infections in Jakarta, Indonesia.
Fuente:Scientific Reports
Extracto:
Lastly, we provide simulated-implied graphs by suppressing 50%
load of cases of the primary infected city in the dominant tree that results in a
reduced Rc , suggesting a potential target of intervention to depress the overall
ARI spread.
institución:(a) Department of Mathematics, Faculty of Mathematics and Natural Sciences, Institut Teknologi Bandung, Bandung, 40132, Indonesia. (b) Department of Mathematics, Faculty of Mathematics and Natural Sciences, Institut Teknologi Bandung, Bandung, 40132, Indonesia.
Conflicto:Los autores declaran no tener conflictos de interés con la investigación
Non-traumatic complete cervical spine dislocation with severe fixed kyphosis: successful multidisciplinary approach to a challenging case.
Non-traumatic complete cervical spine dislocation with severe fixed kyphosis: successful multidisciplinary approach to a challenging case.
Fuente:Journal of Medical Case Reports
Extracto:
This case
illustrates the successful management of a critical situation based on a
multidisciplinary collaboration involving radiologists, anesthesiologists, and
spine surgeons.
An economic evaluation of chronic obstructive pulmonary disease clinical pathway in Saskatchewan, Canada: Data-driven techniques to identify cost-effectiveness among patient subgroups.
An economic evaluation of chronic obstructive pulmonary disease clinical pathway in Saskatchewan, Canada: Data-driven techniques to identify cost-effectiveness among patient subgroups.
Fuente:Plos One
Extracto:
Both manual subgroup analysis and data-driven
policy learning approach showed that the COPD care pathway consistently produced
cost savings and better health outcomes among patients with comorbidities or
among those relatively younger. The care pathway was not cost-effective in the
entire sample.
Cita:PLoS One 2024; 19 (4) : e0301334.
Autor/es:Kuwornu, John Paul (a) Maldonado, Fernando (b)
institución:(a) Australian Centre for Health Services Innovation and Centre for Healthcare Transformation, Faculty of Health, School of Public Health and Social Work, Queensland University of Technology, Brisbane, Queensland, Australia. (b) Health Quality Council, Saskatoon, Saskatchewan, Canada.
Conflicto:Dr. Marciniuk has undertaken consulting with Alberta Health Services, Health Canada, Ontario Ministry of Health and Long-Term Care, Saskatchewan Health Authority, and Yukon Health and Social Services. He has provided research advisory and received research funding (managed and held by University of Saskatchewan) from AstraZeneca, Boehringer Ingelheim, Canadian Institutes of Health Research, GlaxoSmithKline, Grifols, Lung Saskatchewan, Novartis, Sanofi, Saskatchewan Health...
Research Foundation, and Schering-Plough. Dr. Marciniuk is an employee of the University of Saskatchewan, is a Board Member of the Saskatchewan Health Research Foundation and serves as Deputy Editor, CHEST Journal. Dr. Penz reports grants from Saskatchewan Health Research Foundation SPROUT grant, during the conduct of the study; grants and personal fees from Astra Zeneca, grants and personal fees from GlaxoSmithKline, grants and personal fees from Sanofi, personal fees from COVIS Pharma, personal fees from Boehringer Ingelheim, outside the submitted work; and she is the Co-Chair of the Canadian Thoracic Society COPD Assembly. She is the Co-Chair of the ACTonCOPD National Steering Committee. All other authors have no conflicts to disclose. These competing interests do not alter our adherence to PLOS ONE policies on sharing data and materials.
A comparison of software for analysis of rare and common short tandem repeat (STR) variation using human genome sequences from clinical and population-based samples.
A comparison of software for analysis of rare and common short tandem repeat (STR) variation using human genome sequences from clinical and population-based samples.
Fuente:Plos One
Extracto:
Analysis on shared genomic sequence data provided by
the GIAB consortium allows future performance comparisons of new software
approaches on a common set of data, facilitating comparisons and allowing
researchers to choose the best software that fulfils their needs.
Cita:PLoS One 2024; 19 (4) : e0300545.
Autor/es:Oketch, John W (a) Wain, Louise V (b)
institución:(a) Department of Genetics and Genome Biology, University of Leicester, Leicester, United Kingdom. (b) Department of Population Health Sciences, University of Leicester, Leicester, United Kingdom.
Conflicto:Los autores declaran no tener conflictos de interés con la investigación
Comparison of SARS-CoV-2 spike-specific IgA and IgG in nasal secretions, saliva and serum.
Comparison of SARS-CoV-2 spike-specific IgA and IgG in nasal secretions, saliva and serum.
Fuente:Frontiers in Immunology
Extracto:
We further corroborate the superior variant cross-binding
capacity of SIgA in mucosal secretions, highlighting the potential protective
benefits of a vaccine targeting the upper respiratory tract.
institución:(a) Department of Clinical Sciences, Danderyd Hospital, Karolinska Institutet, Stockholm, Sweden. (b) Department of Clinical Sciences, Danderyd Hospital, Karolinska Institutet, Stockholm, Sweden.
Conflicto:The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.
The clinical association of programmed death-1/PD-L1 axis, myeloid derived suppressor cells subsets and regulatory T cells in peripheral blood of stable COPD patients.
The clinical association of programmed death-1/PD-L1 axis, myeloid derived suppressor cells subsets and regulatory T cells in peripheral blood of stable COPD patients.
Fuente:Peerj
Extracto:
The recruitment of MDSCs, accumulation of
Tregs, and up-regulation of CTLA-4 on Treg in COPD, accompanied by an increased
level of PD-1/PD-L1, suggest PD-1/PD-L1 axis may be potentially involved in
MDSCs-induced the expansion and activation of Treg at least partially in COPD.
Claves:COPD, MDSC, PD-1, PD-L1, Treg
Cita:PeerJ 2024; 12 : e16988.
Autor/es:Zhang, Mingqiang (a) Wan, Yinghua (b)
institución:(a) Department of Respiratory and Critical Care Medicine, Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua University, Beijing, China. (b) Department of Respiratory and Critical Care Medicine, Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua University, Beijing, China.
Conflicto:Los autores declaran no tener conflictos de interés con la investigación
The contribution of estimated dead space fraction to mortality prediction in patients with chronic obstructive pulmonary disease-a new proposal.
The contribution of estimated dead space fraction to mortality prediction in patients with chronic obstructive pulmonary disease-a new proposal.
Fuente:Peerj
Tipo de trabajo:Estudio de cohortes
Extracto:
The
predictive formula for dead space fraction enables the estimation of
V(D)/V(Trest), and the mortality probability formula facilitates the estimation
of COPD mortality. However, the clinical implications should be approached with
caution until these formulas have been validated.
Claves:Acute exacerbation, Co-morbidity, Dead space and tidal volume ratio, Lung function, Mortality
Cita:PeerJ 2024; 12 : e17081.
Autor/es:Chuang, Ming-Lung (a) Wang, Yu Hsun (b)
institución:(a) School of Medicine, Chung Shan Medical University, Taichung, Taiwan. (b) Div. Pulmonary Medicine, Department of Internal Medicine, Chung Shan Medical University Hospital, Taichung, Taiwan.
Conflicto:Los autores declaran no tener conflictos de interés con la investigación
Efficacy of second-line chemotherapy in patients with pulmonary large cell neuroendocrine carcinoma.
Efficacy of second-line chemotherapy in patients with pulmonary large cell neuroendocrine carcinoma.
Fuente:Scientific Reports
Extracto:
Second-line chemotherapy, including amrubicin, may be considered
as a treatment option for patients with pulmonary LCNEC.
Cita:Sci Rep 2024 Apr 1; 14 (1) : 7641.
Autor/es:Iida, Yuko (a) Wakuda, Kazushige (b)
institución:(a) Division of Thoracic Oncology, Shizuoka Cancer Center, Shizuoka, Japan. (b) Division of Respiratory Medicine, Department of Internal Medicine, Nihon University School of Medicine, Tokyo, Japan.
Conflicto:Dr. Wakuda reports receiving grants and personal fees from Chugai Pharmaceutical Co., Ltd., grants and personal fees from AstraZeneca K.K., grants from Novartis Pharma K.K., grants from AbbVie, grants from AMGEN, grant and personal fees from MSD K.K., grant and personal fees from Daiichi Sankyo Co., Ltd., grant from Dizal Pharma, personal fees from Taiho Pharmaceutical, Boehringer Ingelheim, Eli Lilly...
K.K, Ono Pharmaceutical, Janssen Pharmaceutical K.K., Takeda Pharmaceutical, and Nihon Kayaku, outside the submitted work. Dr. Kenmotsu reports receiving personal fees from AMGEN, grants and personal fees from AstraZeneca K.K., personal fees from Bayer, personal fees from Boehringer Ingelheim, personal fees from Bristol-Myers Squibb, personal fees from Chugai Pharmaceutical Co., personal fees from Daiichi-Sankyo Co., Ltd., grants and personal fees from Novartis Pharma K.K., grants from Loxo Oncology, grants and personal fees from Ono Pharmaceutical Co, Ltd., grants and personal fees from Eli Lilly K.K., personal fees from Kyowa Hakko Kirin Co., Ltd., personal fees from Taiho Pharmaceuticals, personal fees from Takeda Pharmaceutical Co., Ltd, personal fees from Merck Biopharma Co., Ltd., personal fees from MSD K.K, personal fees from Pfizer, outside the submitted work. Dr. Doshita reports receiving personal fees from Eli Lilly K.K., outside the submitted work. Dr. Mamesaya reports receiving grants and personal fees from Boehringer Ingelheim, personal fees from Chugai Pharmaceutical Co., Ltd., personal fees from Taiho Pharmaceuticals, personal fees from MSD K.K., personal fees from AstraZeneca K.K., personal fees from Ono Pharmaceutical Co., Ltd., outside the submitted work. Dr. Kobayashi reports receiving personal fees from Eli Lilly K.K., personal fees from Novartis Pharma K.K., personal fees from Taiho Pharmaceutical., personal fees from AstraZeneca K.K., personal fees from Chugai Pharmaceutical Co., LTD., and personal fees from Ono Pharmaceutical Co., LTD., outside the submitted work. Dr. Omori reports receiving grants and personal fees from Daiichi-Sankyo Co., Ltd., personal fees from Chugai Pharmaceutical Co., personal fees from AstraZeneca K.K., personal fees from Ono Pharmaceutical Co., Ltd., personal fees from Novartis Pharma K.K., personal fees from Taiho Pharmaceuticals, personal fees from Eli Lilly Japan K.K., personal fees from Daiichi Sankyo Co., Ltd., personal fees from Amgen K.K., outside the submitted work. Dr. Ko reports receiving grants and personal fees from Boehringer Ingelheim, grants from MSD K.K., personal fees from Taiho Pharmaceuticals, personal fees from Chugai Pharmaceutical Co., Ltd., personal fees from Eli Lilly K.K., personal fees from Boehringer Ingelheim, personal fees from Pfizer Inc., and personal fees from AstraZeneca K.K., outside the submitted work. Dr. Ono reports receiving personal fees from AstraZeneca K.K., personal fees from Chugai Pharmaceutical Co., Ltd., and personal fees from Ono Pharmaceutical Co., Ltd., outside the submitted work. Dr. Naito reports receiving grants from Otsuka Pharmaceutical K.K., personal fees from Ono Pharmaceutical Co., Ltd., and personal fees from Helsinn Healthcare SA, outside the submitted work. Dr. Murakami reports receiving grants and personal fees from AstraZeneca K.K., grants and personal fees from Takeda Pharmaceutical Co., Ltd., grants from Daiichi-Sankyo Co., grants and personal fees from AbbVie, grants from IQvia, grants and personal fees from Chugai Pharmaceutical Co., Ltd., personal fees from Ono Pharmaceutical Co., Ltd., personal fees from Bristol-Myers Squibb Japan, personal fees from MSD K.K., personal fees from Pfizer Inc., personal fees from Novartis Pharma K.K., personal fees from Eli Lilly Japan K.K., and personal fees from Taiho Pharmaceuticals, personal fees from Boehringer Ingelheim, personal fees from Eisai, personal fees from Nihon Kayaku, outside the submitted work. Dr. Takahashi reports receiving grants and personal fees from AstraZeneca K.K., grants and personal fees from Chugai Pharmaceutical Co., Ltd., grants and personal fees from Eli Lilly Japan K.K., grants and personal fees from Ono Pharmaceutical Co., Ltd., grants and personal fees from MSD, grants and personal fees from Pfizer Japan Inc., grants and personal fees from Boehringer Ingelheim Japan, grants from Merck Biopharma Co., Ltd., grants from Amgen Inc., personal fees from Roche Diagnostics K.K., personal fees from Takeda Pharmaceuticals Co., Ltd., and personal fees from Yakult Honsha Co. Ltd., outside the submitted work. The remaining authors have nothing to disclose.
The impact of non-pharmaceutical interventions on community non-SARS-CoV-2 respiratory infections in preschool children.
The impact of non-pharmaceutical interventions on community non-SARS-CoV-2 respiratory infections in preschool children.
Fuente:Bmc Pediatrics
Tipo de trabajo:Estudio de cohortes
Extracto:
Non-pharmaceutical interventions strongly reduced the incidence of all
respiratory infections in preschool children but did not affect rhinovirus.
institución:(a) Institute for Medical Epidemiology, Biometrics and Informatics, Interdisciplinary Centre for Health Sciences, Medical Faculty of the Martin Luther University Halle-Wittenberg, Halle (Saale), Germany. (b) Institute for Medical Epidemiology, Biometrics and Informatics, Interdisciplinary Centre for Health Sciences, Medical Faculty of the Martin Luther University Halle-Wittenberg, Halle (Saale), Germany.
Conflicto:Los autores declaran no tener conflictos de interés con la investigación
The safety and potential efficacy of exosomes overexpressing CD24 (EXO-CD24) in mild-moderate COVID-19 related ARDS.
The safety and potential efficacy of exosomes overexpressing CD24 (EXO-CD24) in mild-moderate COVID-19 related ARDS.
Fuente:Respiratory Research
Extracto:
EXO-CD24 presents a promising therapeutic
approach for hyper-inflammatory state and in particular ARDS. Its unique
combination of exosomes, as a drug carrier, and CD24, as an immunomodulator,
coupled with inhalation administration, warrants further investigation in a
larger, international, randomized, quadri-blind trial against a placebo.
Autor/es:Grigoropoulos, Ioannis (a) Tsioulos, Georgios (b)
institución:(a) 4, Department of Internal Medicine, University General Hospital Attikon, Medical School, National and Kapodistrian University of Athens, 12462, Athens, Greece. (b) 4, Department of Internal Medicine, University General Hospital Attikon, Medical School, National and Kapodistrian University of Athens, 12462, Athens, Greece.
Conflicto:Shiran Shapira and Nadir Arber are part time employees of nano24 and have stock options. The conflicts of interest for Justin Stebbing are declared here (https://www.nature.com/onc/editors) and are not relevant. No other authors declare a conflict.
Assessment and clinical utility of metagenomic next-generation sequencing for suspected lower respiratory tract infections.
Assessment and clinical utility of metagenomic next-generation sequencing for suspected lower respiratory tract infections.
Fuente:European Journal of Medical Research
Extracto:
mNGS offers rapid and
precise pathogen detection for patients with suspected LRTIs and shows
considerable promise in diagnosing Mycobacterium tuberculosis and fungal
infections. By broadening the pathogen spectrum and identifying polymicrobial
infections, mNGS can significantly inform and refine antibiotic therapy.
institución:(a) Department of Respiratory and Critical Care Medicine, Anqing 116th Hospital, No.150 Shuangjing Street, Yingjiang District, Anqing, 246004, Anhui, China. chen5751@yeah.net. (b) Department of Respiratory and Critical Care Medicine, Anqing 116th Hospital, No.150 Shuangjing Street, Yingjiang District, Anqing, 246004, Anhui, China.
Conflicto:Weiwei Wu, Jing Li and Jia Liu are employees of Dinfectome Inc., Nanjing, Jiangsu, China. The other authors declare no competing financial interests.
Comparison of the Application of Vibrating Mesh Nebulizer and Jet Nebulizer in Chronic Obstructive Pulmonary Disease
Comparison of the Application of Vibrating Mesh Nebulizer and Jet Nebulizer in Chronic Obstructive Pulmonary Disease
Fuente:International Journal of Chronic Obstructive Pulmonary Disease
Tipo de trabajo:Revisión sistemática
Extracto:
VMN is significantly better than JN in terms of drug delivery
and utilization in the treatment of patients with COPD. However, in the future
use of nebulizers, it is important to select a matching nebulizer based on a
combination of factors such as mechanism of action of the nebulizer, disease type
and comorbidities, ventilation strategies and modes, drug formulations, as well
as cost-effectiveness, in order to achieve the ideal treatment of COPD.
institución:(a) The First Clinical Medical College of Lanzhou University, Lanzhou City, People's Republic of China. (b) The First Clinical Medical College of Lanzhou University, Lanzhou City, People's Republic of China.
Conflicto:Los autores declaran no tener conflictos de interés con la investigación
Tumor-derived exosomal PD-L1: a new perspective in PD-1/PD-L1 therapy for lung cancer.
Tumor-derived exosomal PD-L1: a new perspective in PD-1/PD-L1 therapy for lung cancer.
Fuente:Frontiers in Immunology
Extracto:
This review
aims to elucidate recent insights into the role of exosomal PD-L1 in the field of
immune oncology, emphasizing its potential as a diagnostic, prognostic, and
therapeutic tool in lung cancer.
Claves:PD-L1, exosomes, immune escape, immunotherapy, lung cancer
Cita:Front Immunol 2024; 15 : 1342728.
Autor/es:Wu, Yunjiao (a) Fu, Huichao (b)
institución:(a) Department of Respiratory Medical Oncology, Harbin Medical University Cancer Hospital, Heilongjiang, Harbin, China. (b) Department of Orthopedic Surgery, The Second Affiliated Hospital of Harbin Medical University, Heilongjiang, Harbin, China.
Conflicto:The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Assessing effects of diet alteration on selected parameters of chronically mentally ill residents of a 24-hour Nursing Home. Part 3: Effects of diet modification on selected health indicators.
Assessing effects of diet alteration on selected parameters of chronically mentally ill residents of a 24-hour Nursing Home. Part 3: Effects of diet modification on selected health indicators.
Fuente:Psychiatria Polska
Extracto:
The dietary changes resulted in an
improvement in the tested parameters as well as in reduction in the amount of
food wasted by the residents. There was also a decrease in the number of catarrh
of the upper respiratory tract, which reduced the overall number and quantity of
prescribed drugs.
Claves:chronically mentally ill, health indicators, nutrition
Cita:Psychiatr Pol 2023 Dec 31; 57 (6) : 1195-1211.
Autor/es:Friedrich, Mariola Elżbieta (a) Fugiel, Joanna (b)
institución:(a) Katedra Mikrobiologii Stosowanej i Fizjologii Żywienia Człowieka Wydział Nauk o Żywności i Rybactwa Zachodniopomorski Uniwersytet Technologiczny w Szczecinie. (b) Specjalista ds. żywienia, Dom Pomocy Społecznej im. doktora Edmunda Wojtyły, Szczecin.
Government Initiatives for Research Ethics During COVID-19 Pandemic in Korea.
Government Initiatives for Research Ethics During COVID-19 Pandemic in Korea.
Fuente:Journal of Korean Medical Science
Tipo de trabajo:Revisión
Extracto:
As a result of South Korea's commitment to ethical principles in
their pandemic response, the medical system did not experience collapses due to
the pandemic, and pandemic research was conducted with careful ethical
considerations. The pandemic ethics immunization during the Middle East
respiratory syndrome epidemic in 2015 laid the foundation for prompt government
initiatives that ensured both pandemic research ethics and pandemic response
ethics.
Claves:COVID-19, Research Ethics, Research Ethics Committee, Research Integrity, South Korea
Cita:J Korean Med Sci 2024 Apr 1; 39 (12) : e116.
Autor/es:Park, Young Su (a) Kim, Ock-Joo (b)
institución:(a) Department of the History of Medicine and Medical Humanities, Seoul National University College of Medicine, Seoul, Korea. (b) Department of the History of Medicine and Medical Humanities, Seoul National University College of Medicine, Seoul, Korea. okim9646@snu.ac.kr.
Conflicto:The authors have no potential conflicts of interest to disclose.
Detection of SARS-COV-2 variants and their proportions in wastewater samples using next-generation sequencing in Finland.
Detection of SARS-COV-2 variants and their proportions in wastewater samples using next-generation sequencing in Finland.
Fuente:Scientific Reports
Extracto:
This indicates that the sequencing of wastewater is an effective
way to monitor temporal and spatial trends of SARS-CoV-2 variants at the
population level.
institución:(a) Expert Microbiology Unit, Department of Health Security, Finnish Institute for Health and Welfare, Kuopio, Finland. anssi.lipponen@thl.fi. (b) Institute of Biomedicine, Faculty of Health Sciences, University of Eastern Finland, Kuopio, Finland. anssi.lipponen@thl.fi.
Conflicto:Sami Oikarinen and Kirsi-Maarit Lehto reports a relationship with Greenseq Ltd that includes: board membership. Other authors declare no competing interests.
Alergia
Anestesiología
Bioquímica
Cardiología
Cirugía
Dermatología
Endocrinología y Metabolismo
Enfermería
Gastroenterología
Hematología
Infectología
Inmunología
Medicina Interna
Nefrología
Neumonología
Neurología
Nutrición
Obstetricia y Ginecología
Odontología
Oncología
Otorrinolaringología
Pediatría
Salud Mental
Salud Pública
Urología
Más Especialidades
